AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel

 AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel

AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel

Shots:

  • AstraZeneca launches its digital health program, BeyondBio with the initial investment of $2.8M
  • AstraZeneca in collaborates with JVP to support Israeli start-up companies by providing direct access to databases and leading academic research institutes in digital health with an aim to find technological solutions in the medical sphere
  • The digital health program is operated in collaboration with JVP, the Israel National Initiative Association, Maccabitech Healthcare Research and Innovation Institute and Microsoft. Additionally, AstraZeneca team up with ARC Innovation Center top provide support in research and development targeting challenges in the health care system in Israel

Click here to­ read full press release/ article | Ref: JVP | Image: JVP

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post